← Browse by Condition
Medical Condition

whole brain radiotherapy

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT07443397 Phase 3
Recruiting

Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients.

Enrollment
134 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
View Trial →